SLC2A1 and rheumatoid arthritis: Consistently, RA patients under JAKi therapy showed reduced p-mTOR expression on memory CD8 T cells and a smaller fraction of GLUT1+CD25+ cells within this subset (Fig. 6C), consistent with impaired metabolic activation.